Thomas E. Hughes, Ph.D., is the former CEO of Larimar Therapeutics, where he served from 2008 until 2017. With a Ph.D. in nutritional biochemistry from Tufts University and advanced degrees in Zoology and Biology, he has a strong educational background....
Thomas E. Hughes, Ph.D., is the former CEO of Larimar Therapeutics, where he served from 2008 until 2017. With a Ph.D. in nutritional biochemistry from Tufts University and advanced degrees in Zoology and Biology, he has a strong educational background. His expertise lies in biopharmaceuticals, focusing on obesity, diabetes, and cardiovascular diseases. Before joining Larimar, Thomas worked at Novartis for over 20 years, where he led major drug development projects. He is an inventor on many patents and has published over 40 research papers, showcasing his contributions to medical science. In 2016, he transitioned into a strategic role as President and Chief Scientific Officer after stepping down as CEO, showing his flexibility and commitment to the company's direction. His leadership style emphasizes performance, as seen in his compensation structure that relied heavily on achieving corporate goals. Thomas's decision-making during challenging times, like suspending drug development when necessary, highlights his prudent approach.